EP1104261A1 - Sonde d'electrochirurgie corneenne comportant un site actif de hauteur variable - Google Patents

Sonde d'electrochirurgie corneenne comportant un site actif de hauteur variable

Info

Publication number
EP1104261A1
EP1104261A1 EP99941150A EP99941150A EP1104261A1 EP 1104261 A1 EP1104261 A1 EP 1104261A1 EP 99941150 A EP99941150 A EP 99941150A EP 99941150 A EP99941150 A EP 99941150A EP 1104261 A1 EP1104261 A1 EP 1104261A1
Authority
EP
European Patent Office
Prior art keywords
probe
active site
electrosurgical
electrosurgical probe
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99941150A
Other languages
German (de)
English (en)
Inventor
Thomas A. Silvestrini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Keravision Inc
Original Assignee
Keravision Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Keravision Inc filed Critical Keravision Inc
Publication of EP1104261A1 publication Critical patent/EP1104261A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/1206—Generators therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/1815—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using microwaves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00642—Sensing and controlling the application of energy with feedback, i.e. closed loop control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00684—Sensing and controlling the application of energy using lookup tables
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/0091—Handpieces of the surgical instrument or device
    • A61B2018/00916—Handpieces of the surgical instrument or device with means for switching or controlling the main function of the instrument or device
    • A61B2018/00928—Handpieces of the surgical instrument or device with means for switching or controlling the main function of the instrument or device by sending a signal to an external energy source
    • A61B2018/00934—Handpieces of the surgical instrument or device with means for switching or controlling the main function of the instrument or device by sending a signal to an external energy source the signal being non electric, e.g. pneumatic, hydraulic, optical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B2018/1475—Electrodes retractable in or deployable from a housing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/0079—Methods or devices for eye surgery using non-laser electromagnetic radiation, e.g. non-coherent light or microwaves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/013—Instruments for compensation of ocular refraction ; Instruments for use in cornea removal, for reshaping or performing incisions in the cornea

Definitions

  • the field of invention relates to a procedure for the correction of optical abnormalities in a human eye. More specifically, the field of the invention relates to use of an electrosurgical energy probe which may be of a specific physical configuration as outlined below.
  • This invention also includes suitable electrodes for performing the noted process.
  • the process preferably utilizes a high frequency RF electro-desiccation or ablation device.
  • the procedure involves the initial step of forming at least one access site allowing access to the corneal volume behind the Bowman's layer. It (the access site) preferably is placed in the anterior surface of the cornea through and ending posterior to the Bowman's layer of the eye.
  • the electrosurgical probe is then introduced into the access site and, depending upon the visual abnormality to be corrected, the probe is activated to adjust the volume of the corneal stromal layers through ablation or desiccation.
  • the shape of the volume desiccated or ablated is dependent upon the aberration to be corrected. For instance, if the optical aberration to be alleviated is hyperopia, a circular corneal volume reduction taking place about the outer periphery of the corneal mass may be accomplished. In other instances, such as for the treatment of astigmatism, certain smaller sections of the peripheral corneal volume may be shrunk. In certain circumstances, Bowman's layer may be cut to allow the curvature of the cornea to change after the corneal volume adjustment. These relief cuts may be radial, circular, semicircular or any other form appropriate for the optical adjustment needed. Background of the Invention Anomalies in the overall shape of the eye can cause visual disorders.
  • Hyperopia occurs when the front-to-back distance in the eyeball is too short. In such a case, parallel rays originating greater than 20 feet from the eye focus behind the retina. In contrast, when the front-to-back distance of eyeball is too long, myopia (“nearsightedness”) occurs and the focus of parallel rays entering the eye occurs in front of the retina.
  • Astigmatism is a condition which occurs when the parallel rays of light do not focus to a single point within the eye, but rather have a variable focus due to the fact that the cornea refracts light in a different meridian at different distances. Some degree of astigmatism is normal, but where it is pronounced, the astigmatism must be corrected.
  • Hyperopia, myopia, and astigmatism are usually corrected by glasses or contact lenses.
  • Another method for correcting those disorders is through the implantation of polymeric rings (intrastromal corneal rings or "ICR's") in the eye's corneal stroma to change the curvature of the cornea.
  • ICR's intrastromal corneal rings
  • PMMA polymethylmethacrylate
  • One of the ring devices involves a split ring design which is inserted into a channel previously dissected in the stromal layer of the cornea. A minimally invasive incision is used both for producing the channel and for inserting the implant. See, for instance, the use of PMMA intrastromal rings in U.S. Patent Nos.
  • Surgical methods for the correction of such disorders include radial keratotomy (see, e.g., U.S. Patent Nos. 4,815,463 and 4,688,570) and laser corneal ablation (see, e.g., U.S. Patent No. 4,941,093).
  • the disclosed instrument may also have a bipolar diathermy device with an exterior needle surrounding and coaxial to a fiberoptic member.
  • the diathermy device is used only to coagulate bleeding vessels found on the retinal surface or beneath preretinal membranes. No mention of treating the cornea is mentioned.
  • Two related applications U.S. Patent No. 5,025,811 to Dobrogowski et al., and 5,174,304, to Latina et al, show noninvasive methods for focal transcleral destruction of living human eye tissue. In general, these devices and their underlying procedures involve the use of electric currents for ablating eye tissue, particularly the ciliary process.
  • This invention involves the introduction of an electrosurgical probe into the layers of the cornea to modify local sections of that corneal mass.
  • U.S. Patent No. 4,033,351 shows a bipolar cutting electrode for high frequency surgery.
  • the electrode shows what is said to be an improved electrode design having a number of metal tips.
  • U.S. Patent No. 4,202,337 to Hren et al., shows a similar electrosurgical device for cutting or coagulation. It has a nonconductive handle with a blade assembly having a number of electrodes and an insulation member separating the various electrodes.
  • U.S. Patent No. 4,799,478, to Fedorov et al. teaches a device for the coagulation of biological tissues, preferably corneal tissue.
  • An aspect of the invention provides a method of altering the shape of the cornea, often, the anterior surface curvature of the cornea.
  • the invention also includes certain electrosurgical probe configurations useful in this process.
  • the procedure in its preferred variations, does not entail significant surgical modification of the anterior corneal surface or of the Bowman's layer of the eye, except, in certain situations, adding surface incisions to act either as a stress relief function or to provide access for the electrosurgical probe.
  • An electrosurgical probe is a significant aspect of this invention. It is used, preferably in desiccation or ablation mode, to change the volume of the mass of the cornea posterior to the Bowman's layer and found in the stromal regions of the cornea. By selectively modifying the volume of these regions, small amounts of the cornea may be controllably removed or shrunk and, upon removal of the electrosurgical probe from the cornea, the curvature of the anterior surface of the cornea will have changed and the refractive path of light entering the eye will be changed. As noted above, surface incisions may later be added to permit the anterior of the cornea, in particular, Bowman's layer, to conform to the underlying corneal tissue removal (volume change), thereby allowing for change in anterior corneal curvature.
  • the inventive procedure may be used for the treatment of hyperopia (farsightedness) or myopia.
  • a small incision or access site may be made in the anterior surface of the cornea, which incision extends down through the Bowman's layer or through the sclera and into the intrastromal volume of the cornea.
  • An electrosurgical probe may be introduced through the incision and guided around within the corneal stroma from the outer periphery of the cornea. Activation of the electrosurgical probe in an ablation mode will cause vaporization of the regions of the cornea adjacent to the active areas of the probe. Activating the probe in a desiccation mode will shrink or necrose the region of the cornea adjacent to the active areas of the probe.
  • the probe is removed and the anterior surface then relaxes to conform to the collapse or shrinkage of tissue formed by electrosurgical treatment of the corneal stromal tissue.
  • a modest incision in the anterior of the cornea may be desirable to allow curvature relaxation of the corneal anterior surface.
  • Another preferred procedure includes the alleviation of astigmatism by similar procedure.
  • Small partial depth incisions may be made into the anterior surface of the cornea through Bowman's layer or through the sclera adjacent to the cornea to get under Bowman's layer, but not reaching so far as the posterior corneal surface or the anterior chamber.
  • these initial incisions are made in the regions of the cornea or sclera to allow the electrosurgical probe to reach the corneal mass below the anterior surface which must be reduced to produce a symmetric corneal surface.
  • an electrosurgical probe is then introduced through the incisions and a selected amount of material is removed or desiccated to alleviate the nonregularity of the corneal anterior surface.
  • the active site of the electrosurgical probe is affixed to the top of a piston which can be raised and lowered within the nonconductive material of the electrosurgical probe. In this manner the height of the active site above the nonconductive portion of the probe can be varied, thereby allowing the surgeon to vary the depth of tissue removed during a procedure.
  • a piston which can be raised and lowered within the nonconductive material of the electrosurgical probe.
  • the height of the active site above the nonconductive portion of the probe can be varied, thereby allowing the surgeon to vary the depth of tissue removed during a procedure.
  • Several possible means of raising and lowering the piston within the nonconductive probe are disclosed including pneumatically raising and lowering the piston.
  • Another possible means of raising and lowering the piston includes the use of a thermal expansion element which raises and lowers the piston as the thermal expansion element expands and contracts.
  • a pneumatic balloon-type variable height electrosurgical probe is utilized where the active site region is raised and lowered in relation to the nonconductive portion of the electrosurgical probe by pneumatically inflating the balloon to which the active site is attached. In this manner the height of the active site above the nonconductive portion of the probe can be varied, thereby allowing the surgeon to vary the depth of tissue removed during a procedure.
  • the active site region can be formed from one or several strips of conductive material affixed to the balloon material by an adhesive in such a configuration to allow the balloon material to expand and contract during the raising and lowering of the active site region.
  • the active site region is formed by depositing a thin film. of conductive material on the balloon material in such a manner to allow the balloon to expand and contract.
  • Figure 1 is a schematic illustration of a horizontal section of the eye.
  • Figure 2 is a schematic illustration of the anterior portion of the eye, showing various layers of the cornea.
  • Figures 3A to 3E show a schematic process for treatment of hyperopia using the procedure of this invention.
  • Figures 4A to 4D show schematic diagrams of astigmatic and normal eyes.
  • Figures 5-11 A and B show top and side views of inventive circular RF electrosurgical probes.
  • Figures 5-9 C and D show side views of alternative embodiments of inventive circular RF electrosurgical probes.
  • Figures 12-19 A and B show top and side views of inventive straight RF electrosurgical probes.
  • Figures 12-14 C and D show side views of alternative embodiments of inventive straight RF electrosurgical probes.
  • Figures 17C and D are top views of alternative embodiments of straight RF electrosurgical probes.
  • Figures 20 A and B, and 21 A, B and C show top (A and C) and side (B) views of inventive disc and washer RF electrosurgical probes.
  • Figures 20C and 20D are side sectional views of alternative embodiments of the probe of Figure 20 A.
  • Figures 21D and 21E are side sectional views of alternative embodiments of the probe of Figure 21 A.
  • Figures 21F and 21G are side sectional views of alternative embodiments of the probe of Figure 21C.
  • FIGS 22A and B illustrate sesquipolar probe configurations.
  • Figures 23A-G are schematic diagrams showing top views of eyes wherein various processes for electrosurgically altering corneal curvature have been carried out.
  • Figures 24A-F illustrate an apparatus for positioning a circular electrosurgical probe to perform corneal tissue removal according to the present invention.
  • Figures 25-34 A and B show top views of inventive circular RF electrosurgical probes with inwardly-directed contact end portions and side views of the inwardly-directed contact end portions.
  • Figures 25-28 C and D show side views of alternative embodiments of inwardly-directed contact end portions of inventive circular RF electrosurgical probes with inwardly-directed contact end portions.
  • Figure 35 shows a complementary pair of inventive circular RF electrosurgical probes with inwardly-directed contact end portions.
  • Figure 36A is a side view of an electrosurgical probe having a variable- height active site controlled by a pneumatically activated piston.
  • Figures 36B & C are cross-sectional side views of an electrosurgical probe having a variable-height active site controlled by a pneumatically activated piston as shown in Figure 36A.
  • Figure 36 D is a cross-sectional side view of a piston-type variable-height probe as in Figures 36A-C with a return spring for lowering the piston.
  • Figure 36E is a side view of an electrosurgical probe with a rounded active site region.
  • Figure 36F is a cross-sectional side view of an electrosurgical probe with a piston adapted to accept different active site regions of differing size and shape.
  • Figure 36G is a cross-sectional side view of a piston-type variable-height active site electrosurgical probe which is adjusted by a thermal expansion element.
  • Figure 37A is a side view of an electrosurgical probe having a variable- height active site controlled by a pneumatically activated balloon.
  • Figure 37B is a top view of a pneumatic balloon type variable-height active site electrosurgical probe.
  • Figure 37C is a cross-sectional side view of a pneumatic balloon-type variable-height active site electrosurgical probe.
  • Figure 37D is a top view of a pneumatic balloon-type variable-height active site electrosurgical probe having an active site formed from multiple conductive strips.
  • Figure 37E is a cross-sectional side view of a pneumatic balloon-type variable-height active site electrosurgical probe utilizing a full balloon within a pressure chamber.
  • Figure 37F is a cross-sectional side view of a pneumatic balloon-type variable-height active site electrosurgical probe utilizing an active site that is sputter- deposited onto the surface of a balloon.
  • Figure 38 shows a microprocessor control loop for the probe in accordance with an aspect of the invention.
  • Figure 1 shows a horizontal cross-section of the eye with the globe (11) of the eye resembling a sphere with an anterior bulged spherical portion representing the cornea (12).
  • the globe (11) of the eye consists of three concentric coverings enclosing the various transparent media through which the light must pass before reaching the light- sensitive retina (18).
  • the outermost covering is a fibrous protective portion the posterior five-sixths of which is white and opaque and called the sclera (13), and sometimes referred to as the white of the eye where visible to the front.
  • the anterior one-sixth of this outer layer is the transparent cornea (12).
  • a middle covering is mainly vascular and nutritive in function and is made up of the choroid, ciliary body (16), and iris (17).
  • the choroid generally functions to maintain the retina (18).
  • the ciliary body (16) is involved in suspending the lens (21) and accommodation of the lens.
  • the iris (17) is the most anterior portion of the middle covering of the eye and is arranged in a frontal plane. It is a thin circular disc similar in function to the diaphragm of a camera, and is perforated near its center by a circular aperture called the pupil (19). The size of the pupil varies to regulate the amount of light which reaches the retina (18). It contracts also to accommodation, which serves to sharpen the focus by diminishing spherical aberration.
  • the iris divides the space between the cornea (12) and the lens (21) into an anterior chamber (22) and the posterior chamber (23).
  • the innermost portion of covering is the retina (18), consisting of nerve elements which form the true receptive portion for visual impressions.
  • the retina (18) is a part of the brain arising as an outgrowth from the fore- brain, with the optic nerve (24) serving as a fiber tract connecting the retina part of the brain with the fore-brain.
  • a layer of rods and cones, lying just beneath a pigmented epithelium on the anterior wall of the retina serve as visual cells or photoreceptors which transform physical energy (light) into nerve impulses.
  • the vitreous body (26) is a transparent gelatinous mass which fills the posterior four-fifths of the globe (11). At its sides it supports the ciliary body (16) and the retina (18).
  • a frontal saucer-shaped depression houses the lens.
  • the lens (21) of the eye is a transparent bi-convex body of crystalline appearance placed between the iris (17) and vitreous body (26). Its axial diameter varies markedly with accommodation.
  • this outermost fibrous transparent coating resembles a watch glass. Its curvature is somewhat greater than the rest of the globe and is ideally spherical in nature. However, often it is more curved in one meridian than another giving rise to astigmatism. Most of the refraction of the eye takes place through the cornea.
  • FIG. 2 is a more detailed drawing of the anterior portion of the globe showing the various layers of the cornea (12) making up the epithelium (31).
  • An anterior limiting lamella (33) referred to as Bowman's membrane or layer, is positioned between the epithelium (31) and the stroma (32) of the cornea.
  • the various stroma (32) between the Bowman's layer (33) and the Descemet's membrane (34) are referred to as the corneal mass.
  • the corneal stroma (32) are made up of lamellae having bands of fibrils parallel to each other and crossing the whole of the cornea. While most of the fibrous bands are parallel to the surface, some are oblique, especially anteriorly.
  • a posterior limiting lamella (34) is referred to as Descemet's membrane. It is a strong membrane sharply defined from the stroma (32) and resistant to pathological processes of the cornea.
  • the endothelium (36) is the most posterior layer of the cornea and consists of a single layer of cells and function to maintain transparency of the cornea (12). These epithelial cells are rich in glycogen, enzymes and acetylcholine and their activity regulates the transport of water and electrolytes through the lamellae of the cornea (12).
  • the limbus (37) is the transition zone between the conjunctiva (38) and sclera on the one hand and the cornea (12) on the other.
  • There are a variety of different electrical surgical delivery probes which would be suitable in this invention. In general, there are two distinct electrosurgical delivery probe types: the monopolar probe and the bipolar probe. An in-between electrosurgical configuration applicable to this invention also exists and is known as sesquipolar.
  • the human body In each instance, some section of the human body is used to complete a circuit between one pole and the other.
  • the monopolar probe device there is a single active contact which is inserted or otherwise contacted with the human body and it is the site at which some body activity, e.g., desiccation, ablation, necrosis, fulguration, or the like, takes place.
  • To complete the circuit in a monopolar device there must be another contact which is inactive and placed against the body in a location from the active contact.
  • inactive is meant that only an insignificant temperature rise occurs at that contact point.
  • One such method of insuring that the inactive electrode is in fact “inactive” is to make it quite large in area. This causes the current to spread over a large area for completion of the circuit.
  • a bipolar electrode typically has two equal area active electrodes contained in the same electrode probe-handle structure. This symmetric bipolar electrode design produces a significant temperature rise at both electrodes.
  • the sesquipolar return electrode In a monopolar or sesquipolar configuration, only one electrode has an area of tissue contact producing significant temperature rise. Unlike the monopolar configuration, however, the sesquipolar return electrode is not so remote, and thereby limits current flow through the body to the nearby return electrode.
  • the return electrode area in the sesquipolar configuration electrode is usually at least three times the area of the active electrode and produces little or no tissue effect. In some designs, the sesquipolar return electrode may be found on the electrode probe-handle structure while on other designs it may be separately located in a non-remote region of the body.
  • a high temperature desiccation effect involves heating such that the temperature-time product causes tissue necrosis with little immediate denaturation or discoloration of the tissue.
  • a high temperature desiccation includes heating tissue near the conducting probe contact to approach or slightly exceed 100° C. In the low temperature variation of this procedure, there is a transient decrease in local tissue impedance with little drying of tissue. But in the high temperature variation, there are significant increases in local tissue impedance and also significant in local tissue desiccation.
  • Electrosurgical ablation and cutting produce an effect where a thin layer of tissue is vaporized (cutting) or where a larger section of tissue is vaporized (ablation). The line between "cutting" and “ablation” is not always clear.
  • Blended mode is essentially a combination of the cutting and coagulation (desiccation) modes. In blended mode, cutting or ablation with hemostasis is achieved.
  • the electrosurgical probes may be operated in cutting, ablation, desiccation or blended modes.
  • volume change or "volume modification” refers to the corneal mass being either necrosed, desiccated, ablated or subject to some combination thereof.
  • the current is typically a very high frequency alternating current, typically on the order of 500KHz or more.
  • the RF energy is often delivered in a pulsed or in a more continuous, non-pulsed operation depending on the exact effects desired. Some residual heating will take place no matter which course is taken.
  • J.A For further information concerning the electrical characteristics of electrosurgical waveforms, and electrosurgery in general, please refer to J.A.
  • FIG. 3A through 3D This series of figures shows, in schematic fashion, one procedure for treating hyperopia (farsightedness), myopia, or astigmatism.
  • This schematic procedure shows features which may be common to all of the processes of this invention.
  • the procedure includes the step of producing one or more incisions, often towards the periphery of the cornea. These incisions penetrate Bowman's layer in the anterior surface of the cornea and extend down into, as defined above, "the corneal mass” or “corneal volume.” It is also contemplated that the electrosurgical probe may be inserted into the corneal volume without penetration of the anterior surface of the cornea, e.g., by access through a partial depth incision made in the sclera next to the cornea.
  • an optional step at this point may be the insertion of a non-electrosurgical lamellar separator to separate the various stroma lamellae within the cornea at the depth of the entry incision. This allows the subsequent step of inserting the electrosurgical probe to take place with greater ease.
  • the probe itself may serve the function of intralamellar separator, if so desired.
  • the electrosurgical probe is introduced into the stromal lamellar cavity so produced. Depending upon the design of the inserted electrosurgical probe and on the refractive effect desired, the probe is moved inside the intralamellar space previously formed and activated to desiccate or ablate specific geometric regions of the cornea.
  • the probe may be energized by a common electrosurgical generator such as the Force 2 manufactured by Valleylab, Inc.
  • the generator includes settings for providing the appropriate electrosurgical waveforms for cutting, coagulation or blended modes.
  • the wave shape for each mode is specified in the Valleylab generator manual.
  • Cutting is performed with a 510KHz continuous sinusoid.
  • Coagulation employs a
  • the generator outputs a 5 lOKHz sinusoidal burst at various duty cycles recurring at 3 lKHz.
  • the present invention is not limited to the generators or particular wave shapes and corresponding electrical characteristics disclosed herein.
  • the probe initially may be energized at a low power setting (e.g., 5 watts or lower) for approximately 1-5 seconds or longer.
  • a low power setting e.g., 5 watts or lower
  • the surgeon observes the volume reduction process to ensure that tissue is being safely removed or shrunk from the proper corneal regions. Typically, this observation may be performed in real time through an ophthalmic microscope.
  • the curvature of the corneal surface is then measured. Curvature is typically measured after the probe has been removed to avoid distortion of the corneal surface by the probe itself.
  • One common method for measuring corneal curvature employs the Placido ring technique embodied in the Corneal Topography System manufactured by Eyesys of Houston, Texas.
  • Curvature may also be measured using the technique described in allowed U.S. Patent Application Ser. No. 08/200,241, assigned to the assignee of the present invention, and incorporated by reference herein.
  • the procedure may be repeated if insufficient correction has occurred.
  • the surgeon may increase the output power to reduce a greater volume of tissue until the desired effect is achieved.
  • Bowman's layer and a small amount of underlying stromal tissue may be lightly cut on the anterior surface adjacent to or above the site of the volume reduction to allow the anterior corneal surface to change.
  • Figure 3A shows an eye (100) having a pupil (102) and a cornea (104).
  • a pupil (102) In the outer radius of cornea (104) are two small partial depth incisions (106) which have been cut through Bowman's layer into the corneal mass as shown in Figures 1 and 2. These incisions may be cut radially or circumferentially and are shown for discussion purposes to be radial.
  • FIG. 3 A shows the number of such access sites (106) in Figure 3 A. If a semi-circular lamellar separator (108) as shown in Figure 3B is used, then the number of access sites (106) may be desirably two in number. If lamellar separators of shorter arc segments are used, more numerous slits may be desired. If a nearly circular lamellar separator or electrosurgical probe is used, a single access site (106) may be sufficient.
  • Figure 3B shows the introduction of the optional dissector blade or lamellar separator (108) to separate the lamella found in the cornea. Alternatively, the probe itself may be used to separate the lamella.
  • FIG. 108 The separator (108) is rotated until a circular channel is made in the corneal periphery, and is rotated back out of the eye. A similar procedure takes place on the other access site as shown in Figures 3A and 3B.
  • Figure 3C shows the insertion of an electrosurgical probe (110) into the route formed in the intrastromal region shown in Figure 3B.
  • the probe may be energized following complete insertion or may be energized in a stop, move and activate mode.
  • the step of removing and/or shrinking tissue is continued until sufficient tissue has been ablated or desiccated to achieve the desired refractive effects.
  • Figure 3D shows the eye (100) after completion of the ablation procedure.
  • FIG. 3E shows the eye (100) following relief cuts (114) that may be necessary in some instances to allow the anterior corneal surface to more closely conform to the underlying corneal tissue removal (volume change) thereby allowing for greater change in anterior corneal curvature.
  • These relief cuts may be circumferential as shown or they may be radial depending on the desired refractive effect. Further, the relief cuts may be continuous or may be interrupted as shown. In any case, these cuts may penetrate Bowman's layer and possibly a portion of the underlying corneal stroma.
  • the above-description generally indicates the method of the present invention. Specific probe configurations and method of treatment will be described in the examples below.
  • the inventive electrosurgical method and devices aim to reduce corneal volume in controlled geometric areas of the corneal stroma to achieve refractive correction.
  • the method and devices of the present invention may also be useful in the treatment of astigmatism.
  • Astigmatism occurs, generally, when the curvature of the anterior surface of the cornea is not regular as one passes about the meridians on the anterior surface of the cornea resulting in a steep and flat axis (the astigmatic axis).
  • Figure 4A and 4B are schematic perspective views that show an astigmatic and normal eye, respectively. In an astigmatic eye, two axes are generally identified, corresponding to the steepest (120) and flattest (122) axis of curvature. The steepest axis is also known as the axis of astigmatism (120).
  • Figure 4B shows a normal eye, that is, one in which the curvature of all axes are the same.
  • Figures 4C and 4D show schematic topographical curvature maps of an astigmatic and of a non-astigmatic eye, respectively.
  • region 130 is the steep region whereas region 132 is flatter.
  • the shape need not be nearly circular. It may be, much in the same way as were the lamellar separators (108) in Figure 3B, that the probes have lesser arc length or are straight for alleviating hyperopia. In fact, for treating hyperopia or other maladies, the probe may be of any convenient shape designed to ablate the tissue at hand. Such shapes will be discussed in more detail below. Further it may be noted that the handles of the probes may be straight or bent. The handle also may be a circular barrel to facilitate the vision of the surgeon.
  • a bent handle may allow greater facility of use within the small confines found behind an access site as shown in the above drawings. Additionally, the procedures and devices of the present invention may be useful in the treatment of more than one indication; for example myopia and astigmatism or hyperopia and astigmatism.
  • FIGS 5-11 A and B show top (A) and side (B) views of circular electrosurgical probes suitable for use in the schematic procedure described above.
  • the terms "circular probe” and “substantially hook-shaped probe” refer to an arcuate or substantially circular probe or a probe that otherwise subtends any radial angle of a substantially circular geometric figure. Note that these circular probes may form part of a complementary set, as described below with respect to the circular probes of Figures 25, et seq.
  • Figures 5A and B show a circular RF electrosurgical probe with two active sites that operate in monopolar or sesquipolar modes.
  • the probe (200) includes a shaft (202) and two active sites (204), each active site having an arc of less than about 180°, preferably less than about 90°.
  • the probe has an inner diameter of approximately 6.5 mm and an outer diameter of approximately 8.5 mm.
  • the single source of RF energy (206) is fed in through the insulator (208) making up the probe (200).
  • Figures 6A and B show a circular RF electrosurgical probe (210) with a single active site (212) at the tip. Again, the single source of RF energy (214) is fed in through the insulator making up the probe.
  • Figure 7A and 7B show a circular RF electrosurgical probe (220) with a single active site
  • FIGS. 8 A and B show a circular RF electrosurgical probe (230) with two active sites (232) near the tip of the probe that operate in bipolar fashion. Two sources of RF energy (234 and 236) are fed in through the insulator (238) making up the probe.
  • Figures 9A and 9B show a circular RF electrosurgical probe (230) with two active sites (232) near the tip of the probe that operate in bipolar fashion. Two sources of RF energy (234 and 236) are fed in through the insulator (238) making up the probe.
  • FIG. B show a circular RF electrosurgical probe (240) with a single active site (242) near the tip, the active site shown in Figure 9 A to be on the top part of the probe.
  • a single source of RF energy (244) is fed in through the insulator (246).
  • Figures 10A and B and 11 A and 11B show other circular RF electrosurgical probes (250 and 260 respectively) with single active sites (252 and 262 respectively) near the tips of the probes.
  • a single source of RF energy (254 and 264) is fed in through each probe.
  • Figure 10B shows the active site (252) to be located at the tip but exposed on one side
  • Figure 11B shows the active site (262) to be located at the tip but insulated on the top and thus exposed on one side only.
  • Both probes depicted in Figures 10 A and B and 11 A and B are designed to contact tissue in either the forward or retracting direction to the active site on the probe, the retracting direction.
  • Figures 5-9 C and D show side views of circular electrosurgical probes in which the active sites applied to tissue are raised above a substantial portion of the nonconductive area of the probe.
  • the height of the raised active site controls the depth of the tissue removed. This height is approximately in the range of 0.0-0.55 mm.
  • the raised active site pushes tissue in contact therewith above the larger nonconductive area of the probe.
  • the unraised nonconductive portion acts as a backstop or footplate with respect to the raised active site. In the absence of a raised active site, uniform pressure must be maintained against the tissue in order to remove tissue of uniform depth.
  • the footplate large nonconductive area acts as a stop to prevent the active site from advancing into the tissue to a depth deeper than the height of the raised active site.
  • the active site also may be lower than contact end. That is, the active site may be varied within a well or sunken area.
  • a set of probes having active sites raised to different heights may be provided, so that the surgeon may select the proper probe depending upon the depth (and therefore volume) of tissue to be removed.
  • the surgeon may use multiple probes, e.g., increasing in active site height, until the desired depth of tissue removal is achieved.
  • a single probe may be adapted for use with removable active sites of different heights.
  • the active sites may be coupled to the rest of the probe by any number of well known removable means, including but not limited to pressfit, snap engagement screws, or slideable mounts.
  • a probe having a variable height active site may be provided, allowing the surgeon to adjust the height of the active site depending on the depth (and therefore the volume) of tissue to be removed. During performance of a procedure, the surgeon may vary the height of the active site until the desired depth of tissue removal is achieved.
  • FIGS 36A-36G show one particular embodiment where an active site (3601) is a conductive region located on the top of a piston (3602). Raising and lowering the piston within an insulator making up a probe (3603) varies the height of the active site allowing the surgeon to control the depth of tissue material removed.
  • the piston (3602) in the embodiments shown in Figure 36A-36G can be raised and lowered by several alternative means.
  • the piston (3602) is raised and lowered pneumatically within a hole (3606).
  • the piston (3602) forms an airtight seal on a pressure chamber (3604) located within the probe, which is connected to an air pressure line (3605).
  • a pressure chamber 3604 located within the probe, which is connected to an air pressure line (3605).
  • Several possible means of forming an airtight seal can be employed including, but not limited to, use of O-ring seals, or other covenient or suitable means for providing an airtight seal between the piston and the probe such as a flexible polymer coating on the perimeter of the piston.
  • the hole (3606) is formed in the wall of the pressure chamber (3604) and extends through the nonconducting probe (3603) to the exterior of the probe.
  • the piston (3602) moves within the hole (3606) to vary the height of the active site (3601) above the surface of the nonconductive probe (3603).
  • the piston (3602) is forced in an upward direction, thereby increasing the height of the active site (3601) above the nonconductive portion of the probe (3603).
  • reducing air pressure within the chamber causes the piston to move in a downward direction , thereby reducing the height of the active site (3601) above the nonconductive portion of the probe (3603).
  • the pressure chamber (3604) and air act as an actuator to raise and lower the piston (3602).
  • a flange portion (3608) of the probe (3603) comes in contact with a piston flange (3607) to prevent the piston (3602) from "popping out” of the probe (3603) when excessive air pressure is applied by the surgeon.
  • the air pressure line (3605) passes through the nonconductive material making up the probe (3603) to the probe handle.
  • the line (3605) is attached to and is connected to a pressure regulator (not shown), which can be controlled by the surgeon to change the pressure within the pressure chamber (3604), thereby adjusting the height of the active site (3601). While the present invention utilizes air, other gases or even liquids can be used to increase or decrease pressure within the pressure chamber (3604), thereby raising or lowering the piston (3602), respectively.
  • An RF energy line (3609) passes through the nonconductive material of the probe (3603) and through the piston (3602) to connect to the active site (3601).
  • FIG. 36D An alternate embodiment of the piston-type variable-height electrosurgical probe is shown in Figure 36D, a cross-sectional side view, wherein a return spring (3610) is used to bias or to provide a force to lower the piston (3602) when the pressure within the pressure chamber (3604) decreases.
  • the spring (3610) biases the piston (3602) in a direction of decreasing the height of the active site (3601) i.e. in a downward direction.
  • the piston (3602) has a lower flange (3607) which forms an substantially airtight seal against the side of the nonconductive portion of the probe (3603), thus preventing pressurized air within the pressure chamber (3604) from escaping at an appreciable rate.
  • the spring (3610) is coiled around the piston (3602) and pushes at one end against the piston flange (3607) and at the other end against a probe flange (3608). As pressure within the pressure chamber (3604) decreases, the force of the spring pushing on the piston flange (3607) causes the piston (3602) to move in a downward direction, thereby decreasing the height of the active site (3601) above the nonconductive portion of the probe (3603). Both the pressure chamber (3604) and the spring (3610) act as an actuator to raise and lower the piston (3602).
  • Figures 36A-36G is formed from a conductive layer, made from a material such as copper or stainless steel and having a thickness in a range of 10 microns to about 150 microns or thicker, which is attached to the upper surface of the piston (3602) by a heat resistant adhesive or other heat resistant fasteners.
  • a heat resistant adhesive is used to prevent the active site (3601) from becoming dislodged during the repeated heating and cooling cycles of the ablation procedure.
  • the active site (3601) shown in Figure 36A is flat and circular, extending to cover the entire portion of the upper surface of the cylindrically shaped piston (3602), other embodiments could utilize other shapes and sizes for the active site region (3601) and the piston (3602).
  • a piston with a non-flat upper surface can be utilized to contour the shape of the active site region (3601), as shown in
  • Piston (3602) has a rounded upper surface and the active site (3601) formed thereon has a rounded profile.
  • Piston (3602) also may be fabricated from a suitable metal for improved heat sinking ability.
  • FIG. 36F utilizes a piston adapted to accept different active site regions of differing size or shape.
  • an active site cap (3611) is held onto the piston (3602) by a pair of screws (3612).
  • the cap may be affixed by a biocompatible glue, clips or other fasteners which are well known to those skilled in the art.
  • RF energy is supplied to the active site through an RF connector (3613), which connects to an RF power supply line (3609).
  • RF connector 3613
  • RF power supply line 3609
  • FIG. 36G An alternate embodiment of the piston-type variable-height electrosurgical probe is shown in Figure 36G, wherein a thermal expansion element (3614) is located within the nonconductive portion of the probe (3603) and a piston (3602) with a conductive active site area (3601) is located above and firmly attached to the thermal expansion element (3614).
  • a thermal expansion element 3614
  • the piston moves in an upward direction, thereby increasing the height of the active site (3601) above the nonconductive portion of the probe (3603).
  • contraction by the thermal expansion element (3614) causes the piston (3602) to move downward, thereby lowering the height of the active site (3601).
  • the thermal expansion element (3614) acts as an actuator to raise and lower the piston (3602).
  • a separate power supply line (3615) is provided to the thermal expansion element (3614).
  • the power supply line 3615 is coupled to a power supply (not shown).
  • the surgeon can control the height of the active site (3601).
  • element (3614) may comprise any well known material characterized by a useful coefficient of thermal expansion which enables the desired expansion/height to be achieved.
  • Figures 37A-37B show another embodiment of the present invention wherein an active site (3701) comprises a layer of conductive material attached to a balloon (3702).
  • Figure 37C shows a side cross-sectional view of a probe (3703) shown in Figures
  • the balloon (3702) is constructed from a layer of elastic material and is attached to the probe (3703) in such a manner as to form an airtight barrier over the hole (3706) between the pressure chamber (3704) and the exterior of the probe (3703).
  • the balloon (3702) is attached to the probe in such a manner that as pressure increases within the pressure chamber (3704) the balloon expands, thereby increasing the height of the active site above the nonconductive area of the probe (3703).
  • Means for attaching the balloon (3702) to the edge of the hole (3706) include use of ultrasonic welding, laser welding or an adhesive or suitable mechanical clamping mechanism.
  • one embodiment of the present invention may utilize a ring-shaped clamp (not shown) which applies even pressure to hold the balloon (3702) securely in place and also provides an airtight seal between the balloon (3702) and the walls of the pressure chamber (3704).
  • the ring-shaped clamp may be securely fastened to the nonconductive probe (3703) by four screws (3712) which screw from the exterior of the probe (3703).
  • Figures 37A-37F several embodiments of the balloon-type variable height electrosurgical probe are shown in Figures 37A-37F.
  • the active site (3701) shown in Figure 37A-37B is formed from a flexible layer of conductive material attached to the balloon (3702) by an adhesive.
  • the conductive material of the active site (3701) can be sputter deposited on the balloon (3702) to form a flexible layer that expands with the balloon as the balloon is inflated, as shown in Figure 37F.
  • the active site (3701) is formed from strips of conductive material attached to the balloon (3702) by an adhesive. The sections of the balloon (3702) between the strips of conductive material are able to expand as pressure increases inside the balloon (3702). The spacing between the placement of the strips should be great enough to allow expansion of the balloon (3702) as pressure increases within the chamber (3704).
  • Each of the conductive strips is connected to an RF energy line (3709) which passes through the non-conductive portion of the probe (3703) from the handle of the probe.
  • the active site (3701) is connected to an RF energy line (3709).
  • Suitable materials for balloon construction include any elastic material such as a silicon, thermaplastic elastomers, rubber, neoprene or the same kind of materials used for an angioplasty balloon.
  • the material chosen should be capable of expanding as pressure increases within the pressure chamber without allowing the gas or liquid within the pressure chamber to leak through the balloon material. Acceptable pressure ranges may be on the order of a few psi up to about 400 psi for specialized applications.
  • the adhesive material chosen to secure both the active site (3701) to the balloon (3702) and the balloon to the edge of the hole (3706) should be chosen such that it does not degrade the elasticity, structural integrity, or the ability of the balloon (3702) to seal against leaks from the pressure chamber (3704).
  • FIG. 37C shows the balloon (3702) as a layer of flexible elastic material attached to the edge of the hole (3706)
  • another embodiment shown in Figure 37E could utilize an entire balloon sac (3702) inserted into the pressure chamber (3706) and securely held within said pressure chamber (3706) in such a manner to prevent pressure from the pressure feed line
  • Means for securely holding the balloon within the pressure chamber include the use of an adhesive which securely bonds the balloon to the walls of the pressure chamber (3704).
  • Other securing means include a mechanical clamp holding the mouth of the balloon (3702) in place within the pressure chamber at the connection of the pressure chamber (3704) to the pressure line (3705).
  • Various other clamping mechanisms are possible, which serve to securely anchor the balloon within the pressure chamber, thereby preventing the balloon from becoming dislodged from its position within the pressure chamber (3704).
  • the active site (3701) is a layer of conductive material sputter deposited onto the balloon at low temperature to prevent melting or damaging the balloon (3702). Additionally, standard low temperature sputtering techniques can be employed to cool the balloon target during the sputtering process. Any biocompatible elastomeric material such as polyurethane or any material used for an angioplasty balloon can be used for the balloon, preferably with a thickness of approximately .001 inch.
  • a layer of conductive material can be sputter deposited on the balloon to form the active site layer in accordance with conventional room temperature sputtering techniques which are well known. The important parameter is that the active site layer be thin enough to preserve the desired flexibility of the balloon. This process can be applied to all of the embodiments of the balloon-type variable-height electrosurgical probe.
  • FIGS 36A-G and Figures 37A-F are used by a surgeon to perform corneal tissue removal according to the procedure of the present invention.
  • the surgeon may vary the height of the active site either by varying the pressure supplied to the probe through the air pressure line (3605) or (3705), by use of a pressure regulator (not shown), or by varying the current supplied to a thermal expansion element (3614) by two conductor power supply lines (3615) to the thermal expansion element.
  • the surgeon preferably is provided with a height v. pressure curve which is calibrated for each probe. This tells the surgeon precisely how much current to apply in order to achieve a desired height of the active site.
  • the height v. pressure curve may be embodied in a look up table in a microprocessor.
  • a microprocessor 3800 and position sensor 3802 provide an active feedback control system.
  • the active feedback control system indicates how far the probe 3804 is moved in terms of a height v. pressure curve (not shown) in response to a signal supplied from the position sensor 3802 which is coupled to the probe 3804.
  • the feedback loop prevents the probe 3804 from being moved beyond a predetermined point to ensure a safe insertion point at all times.
  • the position sensor 3802 preferably comprises a transducer capable of critical linear displacement measurements.
  • An example of such a displacement transducer is a differential variable reluctance transducer (DVRT) such as manufactured by MICROSTRAIN®, Inc. of Burlington, Vermont.
  • DVRT differential variable reluctance transducer
  • the displacement transducer/position sensor 3802 measures the position of the probe 3804.
  • a conventional feedback control loop to the microprocessor 3800 then computes the change in pressure necessary to move the probe precisely to a desired position.
  • the internal pressure of the corneal tissue amounts to about 60 mm of mercury. Thus a 1 psi increase in pressure supplied to the balloon as piston produces only a very small change in the height of the active site.
  • a small nonconductive portion immediately adjacent to the active site is also raised above the larger nonconductive area.
  • the raised nonconductive portion covers all or a part of the side area of the active site to limit the conductive area exposed to tissue. This prevents tissue removal from being caused by electrical energy from the covered side areas, thereby giving the surgeon greater assurance that tissue will be removed in a direction normal to the face of the active site and not in other, lateral directions spreading sideways from the raised active site.
  • the insulation of the side areas also increases the current density associated with the face of the active site, providing more efficient tissue removal.
  • Figures 24 A-F illustrate an apparatus for positioning a circular electrosurgical probe to perform corneal tissue removal according to the procedure of the present invention.
  • the circular probe (2400) includes a circular contact end (2402) coupled to a support arm (2404) that is angled with respect to the plane of the circular contact end (2402).
  • the angle may have a value of 0° to 900°.
  • the angle is preferably between 0° and 800°, more preferably between 10° and 500° and most preferably about 340° (+/- 50°).
  • This angle results in the support arm (2404) being generally perpendicular to the corneal surface when the circular contact end (2402) is introduced into the corneal stroma.
  • This angle although not absolutely critical, is desirable and has been found to prevent tearing of the epithelium during the corneal operation.
  • the length of the support arm (2404) is sufficient so that the entire circular contact end is visible through the top of the barrel (2406) during use.
  • Figure 24B illustrates the circular contact end (2402) in greater detail.
  • the contact end (2402) may be rectangular in cross-section as shown in Figure 24B or tapered on its smaller edge as shown in Figure 24C.
  • the contact end may be of any convenient shape, including the rectangular cross-section of Figure 24B or the hexagonal cross-section of Figure 24C in which two opposite sides are longer than the remaining four.
  • the overall relationship of the sizes of the diameter of the arc (2408) of the contact end (2402) to the length of the barrel (2406) is desirably chosen so that the ratio of that length to the arc diameter is between 0.25:1 and 15:1; specifically between 0.4:1 and 1 : 1 , at least about 1 : 1 and less than about 3:1; and at least about 3 : 1 but less than 15:1. These ratios allow easy manipulation by the surgeon.
  • the contact end (2402) has two other physical parameters relevant to effective performance of the surgical procedure. Upon rotation of the barrel (2406), the contact end (2402) must move in a path which is substantially planar.
  • the path of the contact end (2402) as it moves in the corneal intrastromal lamellar channel must not vary either up or down during the barrel (2406) rotation.
  • the distance "a” shown in Figure 24B is chosen so that the contact end (2402) is centered about the axis (2410), which forms the center of the barrel (2406).
  • the cone angle ⁇ (2412) is preferably 112° +/- 30°. Again, this permits the contact end (2402) to traverse a channel which is parallel to the lamella found in the corneal stroma.
  • the cone angle ⁇ (2412) may, of course, vary a few degrees dependent on such variables as the size of the eye and the amount of correction required.
  • all of the circular, disk-shaped, and washer-shaped probes described in this disclosure take on one of the cross-sectional shapes illustrated in Figure 24B or 24C. The active sites of those probes can reside on the central flat portion and/or on the angled portion of the contact end of Figure 24B or 24C.
  • Figure 24D is a side view of an insulated support base used in conjunction with the probe assembly of Figure 24A.
  • the support base includes an annular circumcorneal vacuum ring (2450) and a cylindrical or central bore (2452) extending through the support base.
  • the support base contains a viewing port (2454) to allow a surgeon to view the operational steps which take place at the corneal surface.
  • the vacuum is brought in from a vacuum source line (2456) that is coupled to a vacuum pump (not shown).
  • the vacuum ring (2450) is configured so that it meets with and seals to the front of the eye, rendering the support base relatively immobile when the support base is applied to the front of the eye and a suitable vacuum is applied to the vacuum source line (2456).
  • the vacuum chamber forms an annular vacuum space across the front of the eye.
  • Figure 24E shows a bottom view of the support base in which the circumcorneal vacuum ring (2450) may be clearly viewed.
  • the vacuum ring (2450) is made up of an inner wall (2458) terminating on its inside by the central bore (2452).
  • the central bore (2452) is at least large enough to see the entirety of the circular contact end (2402).
  • the central bore (2452) has an axis which substantially coincides with the axis of the circular contact end (2402).
  • the central bore (2452) is desirably a length such that the ratio of the bore's length to its diameter is between 0.25:1 and 15:1; specifically between 0.4: 1 and 1 : 1 , at least about 1 : 1 and less than about 3 : 1 ; or at least about 3 : 1 up to about 15:1. Preferably, the ratio is about 2.5:1. This sizing allows easy manipulation by the surgeon.
  • the outer vacuum ring wall (2460) desirably forms the outside of the support base. Interior to the vacuum ring (2450) may be one or more ridges (2462) which extend down to the corneal surface when the support base is attached to the eye.
  • ridges may be made of conductive material, while the surrounding support base structure, such as the inner wall (2458) and outer wall (2460), are made of insulating material.
  • the ridges (2462) may be coupled to an electrosurgical generator (not shown). Using this configuration, the ridges (2462) may act as return electrodes when operating in sesquipolar mode. These return electrodes may be positioned to rest on the sclera or translimbal region of the eye.
  • Figure 24F shows an alternative arrangement of return electrodes comprised of radial vanes (2464) that extend downward through the vacuum ring (2450) to make contact with the sclera or translimbal region.
  • Figures 25-34 A and B show top (A) and side (B) views of circular (substantially hook-shaped) probes having inwardly-directed contact end portions suitable for use in the schematic procedure described above.
  • Figure 35 illustrates a complementary pair of probes used to modify an annular 360 degree channel of tissue. One probe of the pair is inserted and rotated in one direction to modify tissue, and then removed. The complementary probe is then inserted and rotated in the other direction to modify the remaining tissue in the channel, and then removed.
  • the circular probes of Figures 25-34 may be employed as part of a complementary set, and may be easily modified to subtend any angle of a circle, not just 180 degrees as shown.
  • the complementary probe subtends an angle of the circle equal to 360 degrees less the radial angle of the first probe, so that a full 360 degree volume of tissue can be ablated or desiccated.
  • a complementary probe set to complete a 360 degree path may be required for treatment of hyperopia and myopia, but not necessarily for astigmatism.
  • Figures 25 A and B show a circular probe (265) having an inwardly- directed contact end portion (269) with a single active site (267).
  • the active site shown in 25B may be open (uninsulated) only on top, or open on the top and the leading side, but insulated on the trailing side (as shown).
  • the sides and the top of the probes described herein may be insulated or open in different combinations.
  • the leading and trailing sides are defined by the direction of rotation, here counterclockwise.
  • FIG. 265 includes a shaft (266) and an active site (267).
  • the probe has an inner diameter of approximately 6.5 mm and an outer diameter of approximately 8.5 mm.
  • the inwardly- directed contact end portion is directed along the radial axis of the circular ring.
  • the single source of RF energy (268) is fed in through the insulative contact end (266) making up the probe (265).
  • Figures 26A and 26B show a circular probe (270) having an inwardly- directed contact end portion with a single active site (271) at the tip. Again, the single source of RF energy (272) is fed in through the insulator making up the probe.
  • Figures 27A and 27B show a circular probe (275) having an inwardly- directed contact end portion with a single active site (276) extending the length of the inwardly-directed contact end portion of the probe.
  • the active site can be of varying thickness, take on different shapes, and be angled within the insulated inwardly-directed portion.
  • the active site shown in Figure 27 is shown as a thin wire to achieve high current density, but may be broader.
  • the active site may also contain bends instead of being straight, or may be angled within the insulated inwardly-directed portion as shown in Figure 33. Rotation of the active site during activation of the probe will remove a disk of corneal tissue for those probes where the active site extends all the way to the center of rotation.
  • the single source of RF energy (277) is fed through the insulator making up the probe.
  • Figures 28A and 28B show a circular probe (280) having an inwardly- directed contact end portion with two active sites (281) that operate in bipolar fashion near the tip of the inwardly-directed contact end portion.
  • Two sources of RF energy (282 and 283) are fed in through the insulator making up the probe.
  • Figures 29 A and B show a circular probe (284) having an inwardly- directed contact end portion with a raised single active site (285) on the leading side with a raised insulated backstop (286) on the trailing side.
  • Figure 29 shows the active site raised with an open top (287), although this top side can also be insulated in an alternative embodiment.
  • a single source of RF energy (288) is fed in through the probe.
  • Figures 30 A and B show a circular probe (289) having an inwardly- directed contact end portion with a single active site (290) located on the leading edge of the probe. As Figure 30B shows, the active site is open only on the leading side and not on the top or trailing sides.
  • Probe (291) in Figure 31 is an alternative embodiment of probe (265) of Figure 25 where the inwardly-directed contact end portion (293) is angled with respect to the radial axis of the circular portion (295). Note that the inwardly-directed portion may alternatively be angled into the area that is a reflection about the radius from the area in which the inwardly-directed portion of Figure 31 lies. All of the active site configurations of probes (270), (275), (280), (284), (289), (298), (500), and (505) can be angled in a similar manner.
  • Probe (298) in Figure 32 is another embodiment of probe (265) illustrating that the inwardly-directed contact end portion (296) can be of variable length. Rotation of this active site during activation of the probe will remove a wide annulus of corneal tissue.
  • Figures 33 A and B show an alternative embodiment of Figures 27 A and B where the active site (501) is angled rather than parallel to the sides of the inwardly- directed contact end portion.
  • Figures 34 A and B show a circular probe (505) having an inwardly- directed contact end portion with two active sites (506 and 507) which may operate in a time multiplexed fashion.
  • Two sources of RF energy (508 and 509) are fed in through the insulator making up the probe.
  • active site (506) is activated during forward (counterclockwise in this example) rotation of the probe while active site (507) is off.
  • active site (507) is activated while active site (506) is off.
  • the use of two smaller active sites rather one larger one allows for a higher current density to be achieved with relatively low power due to the smaller area of each active site.
  • Figures 25-28 C and D show alternative side views of inwardly-directed portions of circular probes with inwardly-directed contact ends where the active sites applied to tissue are raised above a substantial portion of the nonconductive area of the probe.
  • the design and purpose of the raised active sites are the same as that for the circular probes described above.
  • a small nonconductive portion immediately adjacent to the active site is raised on two sides of the active site to limit the conductive area exposed to the tissue.
  • the insulation can also cover the trailing side of the active site and/or the top of the active site to reduce the area further, leaving only the leading side exposed. Alternatively, all sides can be insulated to leave only the top side exposed. This insulation around the active site ensures tissue removal normal only to the open faces of the active site and not in undesired lateral directions. The insulation also increases the current density associated with the open faces of the active site.
  • Figures 12-19 A and B show top (A) and side (B) views of straight electrosurgical probes suitable for use in the schematic procedure described above.
  • Figures 12-19 A and B show top (A) and side (B) views of straight electrosurgical probes suitable for use in the schematic procedure described above.
  • FIGS. 12A and B show a straight RF surgical probe (300) with a single active site (302) extending along the length of the probe. A single source of RF energy (304) is fed through the probe.
  • Figures 13A and B show a straight RF electrosurgical probe (310) with two active sites (312) extending along the length of the probe that operate in bipolar fashion. Two sources of RF energy (314 and 316) are fed in through the insulator (318) making up the probe.
  • Figures 14-19 A and B show other straight RF electrosurgical probes with single active sites near the tips of the probes. A single source of RF energy is fed in through each probe.
  • Figures 14 A and B show the active site (322) to be located near the tip of the probe (320) and on top of the probe such that the active site is raised and pointed in the retracting direction of the probe.
  • Figures 15A and B show the active site (332) similarly located near the tip of the probe. The end of the probe is raised and the active site (332) is located on the raised part of the tip pointing backwards, the active site being exposed on two sides.
  • Figures 16A and B similarly show the active site (342) raised at the end of the probe pointing backwards (340), but the active site is imbedded in the insulating curve of the probe, thereby exposing the active site on one side only.
  • Figures 17A and B show the active site (352) at the tip of a straight probe (350), the active site being exposed on one side on the tip portion alone.
  • Figures 18A and B show the active site (362) near the end of a straight probe (360). The probe is broadened at the active site.
  • Figures 19 A and B again show a straight RF electrosurgical probe (370) with a curved tip, with the active site (372) again raised and pointing backwards and slightly upwards the active site being exposed on one side on the tip portion alone. However, in this embodiment the active site is angled such that a portion (374) of the active site (372) extends beyond the curved tip.
  • the ablation or desiccation takes place either as the device is pushed forward or as it is pulled backwards, or retracted from the lamellar separation channel.
  • the active site Upon exposure to tissue and electrode activation, the active site will vaporize or desiccate the tissue. It may be desirable to provide a second lamellar channel to allow for the relief of gases produced by the probe when used in the ablation mode or to incorporate grooves in the probe portions that insert into the tissue to allow the escape of gases so produced.
  • Figures 12-14C and D are side views of the probes of Figures 12-14A, respectively, for alternative embodiments.
  • the active sites are raised above the larger nonconductive areas.
  • a small nonconductive portion immediately adjacent the active site is also raised above the larger nonconductive area.
  • Figures 17C and D are top views of the probe of Figure 17A for an alternative embodiment.
  • the active site is raised above the larger nonconductive area.
  • a small nonconductive portion immediately adjacent the active site is also raised above the larger nonconductive area.
  • Figures 20 and 21 A and B show top (A) and side (B) views of RF electrosurgical disc and washer probes (400 and 410 respectively).
  • a single RF energy source is fed through each probe.
  • the disc probe (400) is a circular probe with a circular active site (410).
  • the washer probe (410) is a circular probe with a circular active site (412) with a hollow middle (414).
  • Each of these probes may have a flat surface as shown in Figures 20 A and 21 A or may be curved to conform to the curvature of the cornea.
  • the disc probe may have a wire loop surface (415) as shown in Figure 21C.
  • Figures 20C, 21D and 21F are side sectional views of the probes of Figures 20A, 21A and 21C, respectively, for alternative embodiments.
  • the active sites are raised above the larger nonconductive areas.
  • Figures 20D, 21E and 21G are side sectional views of the probes of Figures 20A, 21A and 21C, respectively, for alternative embodiments.
  • a small nonconductive portion immediately adjacent the active site is also raised above the larger nonconductive area.
  • FIGs 22 A and B illustrate the straight probe of Figure 14D and the disc probe of Figure 20A, respectively, in a sesquipolar configuration for removing tissue from a portion of the corneal mass (2200) near the center of the visual axis.
  • Each probe includes a handle (2202) that is angled with respect to the contact end portion (2204) of the probe.
  • An active lead (2206) from an electrosurgical generator (2208) runs into the handle (2202) for connection to the active site (2210).
  • the return electrode (2212) may be placed remotely on the body, e.g., onto a shaved area on the back of the patient's head.
  • the return electrode (2212) is connected to the electrosurgical generator (2208) through a return lead (2214).
  • the return electrode (2212) may be placed on the exterior of the cornea or onto the sclera or translimbal region (2216), as shown.
  • the return electrode (2212) may simply rest in place or be held by a vacuum attachment cavity built into the electrode. Because of its significantly higher area as compared to the active tissue contacting site, the return electrode (2212) does not generate much heat.
  • any of the probes described herein may use a handle, whether angled or not, for the convenience of the surgeon. Further, except for the bipolar probes, any of the probes of the invention may be arranged in the sesquipolar configuration of Figures 22A and B.
  • a second approach to the treatment of an astigmatic eye is to steepen the flat astigmatic axis as shown in Figure 23 A.
  • the lamellar separation zone will be formed in the periphery of the cornea (502).
  • the partial depth incision (500) is placed in the corneal periphery, beneath the astigmatic axis.
  • 260 are operated by insertion into the lamellar tissue, activation, deactivation, rotation to a second position to be desiccated or ablated, activation, and then repeating this procedure until the desired tissue volume has been modified.
  • the choice of RF probe design is dependent on the amount of tissue to be ablated or desiccated.
  • the probe is withdrawn. Relief cuts to the anterior cornea may be necessary as described above to allow the surface of the cornea to conform to the underlying tissue modification. In this way, the flat, astigmatic axis (507) is steepened such that the cornea becomes reasonably symmetrical and spherical.
  • FIG. 25 An alternative to this second approach is to use a circular probe with an inwardly-directed contact end portion. Following separation of the lamellar tissue, one of the probes in Figures 25-34 is inserted through the partial depth incision (500). The probes can be used to change the volume by desiccation or ablation of the tissue (501) under the flat axis of astigmatism axis (507) as shown in Figure 23A. The probes are operated by insertion into the lamellar tissue, activation, deactivation, rotation to a second position to be desiccated or ablated, activation, and then repeating this procedure until the desired tissue volume has been modified. Again, the choice of RF probe design is dependent on the amount of tissue to be ablated or desiccated.
  • the probe is withdrawn. Because astigmatic correction typically does not require tissue modification along a full 360 degrees, modification with one probe, rather than a complementary pair, may be sufficient. Again, relief cuts on the anterior corneal surface may be necessary as described above to allow the surface of the cornea to conform to the underlying tissue removal.
  • a circular intrastromal channel may first be made using the apparatus of US Patent No. 5,403,335, issued to Loomas et al, and assigned to the assignee of the present invention. That patent is incorporated by reference herein in its entirety.
  • the support base of Figures 24D-F may be substituted for the support base of the Loomas patent so as to provide a sesquipolar return electrode for use during the later stage of tissue volume reduction.
  • one of the circular probes or one of the circular probes with an inwardly-directed contact end portion described herein is inserted through the partial depth incision (512).
  • the assembly of Figures 24A-D may be employed. If using the latter type of probe, the radial inwardly-directed contact end portion is first inserted without using the support base shown in Figure 24D. The support base is then slipped over the barrel, or alternatively, the procedure is performed freehand. For the former probe type, the base may be in place over the eye during initial insertion. Once the guide is in place, the barrel is rotated and the rest of the circular probe enters the cornea.
  • the probe is then activated to change the volume by ablation or desiccation of the tissue (514) in the channel.
  • This procedure may also be employed to correct myopia or astigmatism, using the probes and motions appropriate for those corrections.
  • the choice of RF probe design is dependent on the amount and location of tissue to be ablated or desiccated.
  • Circular probes (210), (220), (230), (240), (250) and (260) will allow for desiccation of the channel.
  • Circular probe (220) is operated by inserting it into the lamellar tissue, activating it, deactivating it, and then removing it.
  • the other circular probes are operated by inserting them into the lamellar tissue, activating, deactivating, rotating to a second position to be ablated, activating, deactivating and repeating this process until the entire channel is desiccated, and then removing it.
  • Circular probes (210), (240), (250) and (260) will allow for ablation of the channel.
  • the probes are operated by insertion into the lamellar tissue, activation, deactivation, rotation to a second position to be ablated, activation, and repeating until the entire channel is ablated, followed by removal of the probe.
  • Circular probes (250) and (260) can also be operated by complete insertion into the lamellar tissue, activation, deactivation, pulling partially back out of the tissue to a second position to be ablated, activation, deactivation and repetition of this process until the entire channel is ablated, followed by removal of the probe.
  • relief cuts in the anterior of the cornea may be necessary as described above to allow the surface of the cornea to conform to the underlying tissue removal. In this way, the central corneal surface is steepened such that the cornea curvature is improved.
  • Circular probes with inwardly-directed contact end portions (265), (284), (289), (291), and (298), for example, will also allow for either desiccation or ablation of the channel to correct for hyperopia.
  • the other probes may also be used if modified to remove an annulus of tissue for hyperopic correction.
  • the probes are operated using a clockwise/counterclockwise set. First, one probe is inserted into the lamellar tissue, activated, deactivated, rotated to a second position to be ablated or desiccated, activated, and repeated until half the circular channel is ablated or desiccated, followed by removal of the probe.
  • the complementary probe is then inserted into the lamellar tissue, activated, deactivated, rotated to a second position in the opposite direction than that of the first probe to be ablated or desiccated, activated, and repeated until the second half of the circular channel is ablated or desiccated, followed by removal of the probe.
  • relief cuts in the anterior of the cornea may be necessary as described above to allow the surface of the cornea to conform to the underlying tissue removal. In this way, the central corneal surface is steepened such that the cornea curvature is improved.
  • a second approach to the treatment of a hyperopic eye is to use a straight RF probe.
  • 2 or more partial depth incisions (510) are made in the periphery and 2 or more radial lamellar separation zones are formed as shown in Figures 23D and 23E.
  • one of the straight RF probes shown in Figures 12-19 A and B is inserted through each partial depth incision (510) in the lamellar separation zones (512) and (514).
  • the probe is then activated to change the volume by ablation or desiccation of the tissue in the channel.
  • the choice of RF probe design is dependent on the amount of tissue to be ablated or desiccated. Probes (300), (310), (320), (330), (340), (350), (360) and (370) will allow for desiccation of the channel.
  • Probes (300) and (310) are operated by insertion into the lamellar tissue, activation, deactivation, and then removal.
  • Probes (320), (330), (340), (350), (360) and (370) are operated by inserting into the lamellar tissue, activating, deactivating, moving to a second position to be ablated, activating, deactivating and repeating this process until enough of the channel is desiccated, and then removing the probe. In this way the tissue desiccated can either form a continuous path (516) or can be interrupted points along the radial lamellar separation channel (518). Probes (320)-(370) will allow for ablation of corneal volume inside the radial lamellar separation channel.
  • Probes (320), (340), (350), (360) and (370) are operated by insertion into the lamellar tissue, activation, deactivation, moving it further into the tissue to a second position to be ablated, activation, and repeating until the entire channel is ablated, and then removal.
  • the same probes can also be operated by complete insertion into the lamellar separation channel, activation, deactivation, pulling back out of the tissue channel to a second position to be ablated, activation, deactivation and repetition of the process until the enough of the channel is ablated, followed by removal of the probe.
  • relief cuts may be necessary in the anterior cornea as described above to allow the surface of the cornea to conform to the underlying tissue removal. In this way, the corneal surface is steepened centrally such that the corneal curvature is improved.
  • radial or circumferential partial depth incisions are made in the periphery of the cornea.
  • a lamellar separator is inserted to create a radial lamellar separation channel (522) toward the center of the pupil for the insertion of the electrical probe.
  • the lamellar path (522) will be formed under or near the central or paracentral portion of the cornea.
  • one of the straight RF probes shown in Figures 14-19 A and B or the disc or washer probes shown in Figures 20-21 A and B is inserted through the peripheral partial depth incision (520) into the lamellar separation channel (522).
  • the probe is then activated to change the volume by ablation of the tissue in the channel, the volume change (524) resulting from the use of the disc-shaped probe (400) is shown in Figure 23F and volume change (526) resulting from the use of the washer-shaped probe (410) is shown in Figure
  • Probes (320)-(370) will allow for ablation of the channel.
  • the probes are operated by insertion into the lamellar tissue, activation, deactivation, advancing the probe into the channel to a second position to be ablated, activation, deactivation, repeating the process until the entire channel is ablated, and then the probe is removed.
  • the probes can also be operated by complete insertion into the lamellar separation channel, activation, deactivation, pulling out of the channel to a second position to be ablated, activation, deactivation and repeating the process until the entire channel is ablated, and then the process is removed.
  • Probes (400) and (410) are operated by insertion into the lamellar separation channel (522), activation, deactivation and removal from the channel. Again, relief cuts in the anterior cornea may be necessary as described above to allow the surface of the cornea to conform to the underlying tissue removal. In this way, the corneal surface in the central corneal area is flattened such that the corneal curvature is improved.
  • a second approach to the treatment of a myopic eye is to use a complementary pair of circular probes with inwardly-directed contact end portions.
  • a lamellar separator is first inserted to create a radial lamellar separation channel toward the center of the pupil for the insertion of the electrical probe.
  • probe (270), (275), (280), (500), or (505), for example is inserted through the peripheral partial depth incision into the lamellar separation channel.
  • Other probes may be used if modified to remove tissue from a central corneal area to correct myopia.
  • the probe is operated by activation, deactivation, advancement of the probe into the channel to a second position to be ablated or desiccated, activation, deactivation, and repeating the process until the radial inwardly-directed contact end portion has rotated 180 degrees and half the radial channel is ablated or desiccated.
  • the probe is then removed and the complementary probe is inserted and operated in the same manner as the first probe, but rotated 180 degrees in the opposite direction so that the entire radial channel is ablated or desiccated as shown in Figure 23F.
  • relief cuts in the anterior cornea may be necessary as described above to allow the surface of the cornea to conform to the underlying tissue removal.

Landscapes

  • Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plasma & Fusion (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Surgical Instruments (AREA)

Abstract

L'invention concerne un dispositif et une procédure de correction d'anormalités optiques d'un oeil humain, impliquant l'utilisation d'une sonde d'énergie électrochirurgicale qui présente des configurations physiques spécifiques. Le procédé emploie de préférence un dispositif d'électrodessèchement ou d'ablation haute fréquence HF. La procédure comporte l'étape initiale consistant à former au moins un site d'accès permettant d'accéder au volume cornéen situé derrière la couche de Bowman. Ce site est placé de préférence dans la surface antérieure de la cornée, traverse la couche de Bowman de l'oeil et se termine derrière celle-ci. On introduit ensuite la sonde d'électrochirurgie dans le site d'accès, et, en fonction de l'anormalité visuelle à corriger, on l'active de façon à régler le volume des couches de stroma cornéen par ablation ou dessèchement. La forme du volume desséché ou oblitéré dépend de l'aberration à corriger. On peut régler la profondeur du tissu oblitéré en faisant varier la hauteur du site électriquement actif de la sonde d'électrochirurgie. On peut faire varier la hauteur en levant ou en baissant un piston (3602) supportant le site actif. Le piston (3602) peut être levé ou baissé pneumatiquement, ou par fixation à un élément d'expansion thermique commandé électriquement qui lève ou baisse le piston à mesure que l'élément d'expansion thermique s'étend ou se contracte. Dans un autre mode de réalisation, le site actif peut être situé sur une matière de type ballonnet qui est gonflée pneumatiquement pour modifier la hauteur du site actif situé au-dessus de la partie non conductrice de la sonde d'électrochirurgie.
EP99941150A 1998-08-13 1999-08-13 Sonde d'electrochirurgie corneenne comportant un site actif de hauteur variable Withdrawn EP1104261A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13373498A 1998-08-13 1998-08-13
US133734 1998-08-13
PCT/US1999/018519 WO2000009027A1 (fr) 1998-08-13 1999-08-13 Sonde d'electrochirurgie corneenne comportant un site actif de hauteur variable

Publications (1)

Publication Number Publication Date
EP1104261A1 true EP1104261A1 (fr) 2001-06-06

Family

ID=22460072

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99941150A Withdrawn EP1104261A1 (fr) 1998-08-13 1999-08-13 Sonde d'electrochirurgie corneenne comportant un site actif de hauteur variable

Country Status (3)

Country Link
EP (1) EP1104261A1 (fr)
AU (1) AU5485999A (fr)
WO (1) WO2000009027A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482224B1 (en) 1996-08-22 2002-11-19 The Trustees Of Columbia University In The City Of New York Endovascular flexible stapling device
US7377917B2 (en) * 2002-12-09 2008-05-27 The Trustees Of Dartmouth College Feedback control of thermokeratoplasty treatments
US7186251B2 (en) 2003-03-27 2007-03-06 Cierra, Inc. Energy based devices and methods for treatment of patent foramen ovale
US7293562B2 (en) 2003-03-27 2007-11-13 Cierra, Inc. Energy based devices and methods for treatment of anatomic tissue defects
US7972330B2 (en) 2003-03-27 2011-07-05 Terumo Kabushiki Kaisha Methods and apparatus for closing a layered tissue defect
US7165552B2 (en) 2003-03-27 2007-01-23 Cierra, Inc. Methods and apparatus for treatment of patent foramen ovale
CA2519636A1 (fr) 2003-03-27 2004-10-14 Cierra, Inc. Procedes et appareil pour le traitement de foramen ovale permeable
US6939348B2 (en) 2003-03-27 2005-09-06 Cierra, Inc. Energy based devices and methods for treatment of patent foramen ovale
US8021362B2 (en) 2003-03-27 2011-09-20 Terumo Kabushiki Kaisha Methods and apparatus for closing a layered tissue defect
US7367975B2 (en) 2004-06-21 2008-05-06 Cierra, Inc. Energy based devices and methods for treatment of anatomic tissue defects
JP5033787B2 (ja) 2005-04-11 2012-09-26 テルモ株式会社 層状組織の欠損の閉鎖をもたらすための方法および装置
US8992516B2 (en) 2007-07-19 2015-03-31 Avedro, Inc. Eye therapy system
EP2355739A4 (fr) 2008-11-11 2014-03-12 Avedro Inc Système de thérapie oculaire
ES2372082B1 (es) * 2010-03-02 2013-01-30 Consejo Superior De Investigaciones Científicas (Csic) Sensor no invasivo para determinar características funcionales de la córnea y dispositivo que incluye dicho sensor.
CN115507735B (zh) * 2022-11-22 2023-03-17 山东天厚新材料科技有限公司 一种铜箔厚度测量装置

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4326529A (en) * 1978-05-26 1982-04-27 The United States Of America As Represented By The United States Department Of Energy Corneal-shaping electrode
US4688570A (en) 1981-03-09 1987-08-25 The Regents Of The University Of California Ophthalmologic surgical instrument
US4671276A (en) 1982-01-04 1987-06-09 Kera Associates Apparatus for corneal curvature adjustment
US4961744A (en) 1982-01-04 1990-10-09 Keravision, Inc. Holder for inserting corneal curvature adjustable ring
US4766895A (en) 1982-01-04 1988-08-30 Kera Corneal Devices, Inc. Apparatus for corneal curvature adjustment
US4452235A (en) 1982-01-04 1984-06-05 Reynolds Alvin E Method for corneal curvature adjustment
FR2556953B1 (fr) 1983-12-21 1986-05-16 Hanna Khalil Appareil chirurgical pour keratotomie radiaire
US5779698A (en) * 1989-01-18 1998-07-14 Applied Medical Resources Corporation Angioplasty catheter system and method for making same
US5749871A (en) * 1993-08-23 1998-05-12 Refractec Inc. Method and apparatus for modifications of visual acuity by thermal means
US5445637A (en) * 1993-12-06 1995-08-29 American Cyanamid Company Method and apparatus for preventing posterior capsular opacification
WO1995021578A1 (fr) * 1994-02-09 1995-08-17 Keravision, Inc. Traitement electrochirurgical de la cornee

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0009027A1 *

Also Published As

Publication number Publication date
WO2000009027A9 (fr) 2000-08-03
AU5485999A (en) 2000-03-06
WO2000009027A1 (fr) 2000-02-24

Similar Documents

Publication Publication Date Title
US20020049437A1 (en) Electrosurgical procedure for the treatment of the cornea
US5599341A (en) Laser surgical procedure and device for treatment of the cornea
US20020013579A1 (en) Rotating electrosurgical blade for corneal reshaping
RU2194470C2 (ru) Устройство для коррекции остроты зрения с помощью тепловых средств
US5749871A (en) Method and apparatus for modifications of visual acuity by thermal means
US6213997B1 (en) Apparatus for modifications of visual acuity by thermal means
US20070055227A1 (en) Probe used for an ocular procedure
EP1104261A1 (fr) Sonde d'electrochirurgie corneenne comportant un site actif de hauteur variable
US20060064083A1 (en) Multi-tip probe used for an ocular procedure
JP2005324055A (ja) 熱手段による視力の変更
US20060184166A1 (en) Method and apparatus to automatically insert a probe into a cornea
US20040049186A1 (en) Method and apparatus for modifications of visual acuity by thermal means
JP2003275234A (ja) 視力の矯正に使用する加熱角膜形成システム用の電極アセンブリ
EP1262156B1 (fr) Modifications de l'acuité visuelle par des moyens thermiques
AU1826901A (en) Method and apparatus for modifications of visual acuity by thermal means

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010215

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 20020521